Under pathological conditions such as brain tumors and neuroinflammation, AlNPs accumulate more efficiently through mechanisms including SPARC binding, EPR in leaky vasculature, and preservation of nanoparticle integrity due to net negative charge at physiological pH (−15 to −20 mV) [73,74]. The gene discussed is SPARC; the disease is brain neoplasm.